However, the risk of aspiration due to delayed gastric emptying has raised concern regarding the safety of GLP-1 agonists in the perioperative setting : The ANZCA Safety and Quality Committee recently presented two case reports of gastric contents identified on elective gastroscopy in patients using GLP-1 agonists despite adequate fasting times
After one, three, and six months, subjects returned to the clinic to return their unused capsules and receive new capsules
At the recommended 10mg / 2 ml mix (5 mg/ml): 0.5 mg = 10 units, 1.0 mg = 20 units, 1.5 mg = 30 units, 2.0 mg = 40 units
Clinicians should refer to official prescribing information, regulatory updates, and conduct individualized patient assessments when making therapeutic decisions
Add fiber gradually (too fast causes bloating)
The European Medicines Agency began investigating reports in 2023, and the FDA has acknowledged similar adverse event submissions in the United States